Health
New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy – News-Medical.Net
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based…
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients.
The approach, described online today in the journal Science Advances, could lead to a treatment for DMD and inform the treatment of other inherited diseases.
Thousands of different mutations causing Duchenne have been identified, but they…
-
Noosa News18 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business19 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News22 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business23 hours agoDividends from ASX 200 bank shares ‘looking very stretched’: expert